Crosstalk between DNA repair and cancer stem cell (CSC) associated intracellular pathways

Seminars in Cancer Biology

Volumn 31, Issue , 2015, Pages 36-42

  Skvortsov, Sergej ^a   Debbage, Paul ^a   Lukas, Peter ^a   Skvortsova, Ira ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Ape1 Ref 1; Cancer stem cells; DNA repair; Intracellular signalling; MRN complex

Indexed keywords

ABC TRANSPORTER; CISPLATIN; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; MRE11 PROTEIN; NIBRIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAC1 PROTEIN; RAD50 PROTEIN; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; ANTINEOPLASTIC AGENT; APEX1 PROTEIN, HUMAN;

CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL SUBPOPULATION; CELL SURVIVAL; DNA REPAIR; DNA STRAND BREAKAGE; EPITHELIAL MESENCHYMAL TRANSITION; EXCISION REPAIR; GENE ACTIVATION; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; BIOLOGICAL MODEL; DNA DAMAGE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; DNA DAMAGE; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 84923221727     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.06.002     Document Type: Review

References (63)

1. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011, 17:313-319.
2. Kinsella T.J. Coordination of DNA mismatch repair and base excision repair processing of chemotherapy and radiation damage for targeting resistant cancers. Clin Cancer Res 2009, 15:1853-1859.
3. Kelley M.R., Cheng L., Foster R., Tritt R., Jiang J., Broshears J., et al. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 2001, 7:824-830.
4. Fishel M.L., Jiang Y., Rajeshkumar N.V., Scandura G., Sinn A.L., He Y., et al. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther 2011, 10:1698-1708.
5. Evans A.R., Limp-Foster M., Kelley M.R. Going APE over ref-1. Mutat Res 2000, 461:83-108.
6. Skvortsova I., Skvortsov S., Stasyk T., Raju U., Popper B.A., Schiestl B., et al. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 2008, 8:4521-4533.
7. Zhang Y., Wang J., Xiang D., Wang D., Xin X. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor. Int J Oncol 2009, 35:1069-1079.
8. Kelley M. DNA repair in cancer therapy: molecular targets and clinical applications 2012, Elsevier Inc., San Diego, USA.
9. Wang K., Zhang T., Dong Q., Nice E.C., Huang C., Wei Y. Redox homeostasis: the linchpin in stem cell self-renewal and differentiation. Cell Death Dis 2013, 4:e537.
10. Nagano O., Okazaki S., Saya H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 2013, 32:5191-5198.
11. Blanpain C., Mohrin M., Sotiropoulou P.A., Passegue E. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 2011, 8:16-29.
12. Domenis R., Bergamin N., Gianfranceschi G., Vascotto C., Romanello M., Rigo S., et al. The redox function of APE1 is involved in the differentiation process of stem cells toward a neuronal cell fate. PLoS ONE 2014, 9:e89232.
13. Gurusamy N., Mukherjee S., Lekli I., Bearzi C., Bardelli S., Das D.K. Inhibition of ref-1 stimulates the production of reactive oxygen species and induces differentiation in adult cardiac stem cells. Antioxid Redox Signal 2009, 11:589-600.
14. Tell G., Quadrifoglio F., Tiribelli C., Kelley M.R. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009, 11:601-620.
15. Vascotto C., Cesaratto L., Zeef L.A., Deganuto M., D'Ambrosio C., Scaloni A., et al. Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009, 9:1058-1074.
16. Wang L., Huang X., Zheng X., Wang X., Li S., Zhang L., et al. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy. Int J Biol Sci 2013, 9:472-479.
17. Liu L., Salnikov A.V., Bauer N., Aleksandrowicz E., Labsch S., Nwaeburu C., et al. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-kappaB downregulation. Int J Cancer 2014, 34:2489-2503.
18. Kelley M.R., Georgiadis M.M., Fishel M.L. APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1. Curr Mol Pharmacol 2012, 5:36-53.
19. Chan N., Milosevic M., Bristow R.G. Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies. Future Oncol 2007, 3:329-341.
20. Tell G., Damante G., Caldwell D., Kelley M.R. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?. Antioxid Redox Signal 2005, 7:367-384.
21. Skvortsov S., Debbage P., Skvortsova I. Proteomics of cancer stem cells. Int J Radiat Biol 2013, 12:1-6.
22. Skvortsov S., Debbage P., Cho W.C., Lukas P., Skvortsova I. Putative biomarkers and therapeutic targets associated with radiation resistance. Expert Rev Proteomics 2014, 11(2):207-214.
23. Yoon C.H., Hyun K.H., Kim R.K., Lee H., Lim E.J., Chung H.Y., et al. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells. FEBS Lett 2011, 585:2331-2338.
24. Skvortsov S., Dudas J., Eichberger P., Witsch-Baumgartner M., Loeffler-Ragg J., Pritz C., et al. Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). Br J Cancer 2014, 110(11):2677-2687.
25. Kato T., Fujita Y., Nakane K., Mizutani K., Terazawa R., Ehara H., et al. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signalling. Cytokine 2013, 64(1):251-257.
26. Yang W.H., Lan H.Y., Huang C.H., Tai S.K., Tzeng C.H., Kao S.Y., et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 2012, 14:366-374.
27. Skvortsov S., Jimenez C.R., Knol J.C., Eichberger P., Schiestl B., Debbage P., et al. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets. Radiother Oncol 2011, 101:177-182.
28. German P., Szaniszlo P., Hajas G., Radak Z., Bacsi A., Hazra T.K., et al. Activation of cellular signaling by 8-oxoguanine DNA glycosylase-1-initiated DNA base excision repair. DNA Repair (Amst) 2013, 12:856-863.
29. Hajas G., Bacsi A., Guilera-Aguirre L., Hegde M.L., Tapas K.H., Sur S., et al. 8-Oxoguanine DNA glycosylase-1 links DNA repair to cellular signaling via the activation of the small GTPase Rac1. Free Radic Biol Med 2013, 61C:384-394.
30. Michaelson D., Abidi W., Guardavaccaro D., Zhou M., Ahearn I., Pagano M., et al. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008, 181:485-496.
31. Yan Y., Greer P.M., Cao P.T., Kolb R.H., Cowan K.H. RAC1 GTPase plays an important role in gamma-irradiation induced G2/M checkpoint activation. Breast Cancer Res 2012, 14:R60.
32. Johnson M.A., Sharma M., Mok M.T., Henderson B.R. Stimulation of in vivo nuclear transport dynamics of actin and its co-factors IQGAP1 and Rac1 in response to DNA replication stress. Biochim Biophys Acta 2013, 1833:2334-2347.
33. Luo M., Kelley M.R. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone. Anticancer Res 2004, 24:2127-2134.
34. Wang D., Luo M., Kelley M.R. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004, 3:679-686.
35. Nagaria P., Robert C., Rassool F.V. DNA double-strand break response in stem cells: mechanisms to maintain genomic integrity. Biochim Biophys Acta 2013, 1830:2345-2353.
36. Curtin N. Therapeutic potential of drugs to modulate DNA repair in cancer. Expert Opin Ther Targets 2007, 11:783-799.
37. Williams G.J., Lees-Miller S.P., Tainer J.A. Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair (Amst) 2010, 9:1299-1306.
38. Bruhn C., Zhou Z.W., Ai H., Wang Z.Q. The essential function of the MRN complex in the resolution of endogenous replication intermediates. Cell Rep 2014, 6:182-195.
39. Kuroda S., Urata Y., Fujiwara T. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization. Acta Med Okayama 2012, 66:83-92.
40. Cerosaletti K., Concannon P. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm. J Biol Chem 2004, 279:38813-38819.
41. Yang M.H., Chang S.Y., Chiou S.H., Liu C.J., Chi C.W., Chen P.M., et al. Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene 2007, 26:1459-1467.
42. Yang M.H., Chiang W.C., Chou T.Y., Chang S.Y., Chen P.M., Teng S.C., et al. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res 2006, 12:507-515.
43. Chen Y.C., Su Y.N., Chou P.C., Chiang W.C., Chang M.C., Wang L.S., et al. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J Biol Chem 2005, 280:32505-32511.
44. Cheng L., Wu Q., Huang Z., Guryanova O.A., Huang Q., Shou W., et al. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1. EMBO J 2011, 30:800-813.
45. Li X.R., Ji F., Ouyang J., Wu W., Qian L.Y., Yang K.Y. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 2006, 32:1130-1134.
46. Gastonguay A., Berg T., Hauser A.D., Schuld N., Lorimer E., Williams C.L. The role of Rac1 in the regulation of NF-kappaB activity, cell proliferation, and cell migration in non-small cell lung carcinoma. Cancer Biol Ther 2012, 13:647-656.
47. Koh M.S., Moon A. Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells. Biochem Biophys Res Commun 2011, 406:25-29.
48. Ma Q., Cavallin L.E., Yan B., Zhu S., Duran E.M., Wang H., et al. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci USA 2009, 106:8683-8688.
49. Ismail I.H., Andrin C., McDonald D., Hendzel M.J. BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J Cell Biol 2010, 191:45-60.
50. Allegra E., Caltabiano R., Amorosi A., Vasquez E., Garozzo A., Puzzo L. Expression of BMI1 and p16 in laryngeal squamous cell carcinoma. Head Neck 2013, 35:847-851.
51. Mavila N., James D., Utley S., Cu N., Coblens O., Mak K., et al. Fibroblast growth factor receptor-mediated activation of AKT-beta-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells. PLoS ONE 2012, 7:e50401.
52. Jin F., Liu C., Guo Y., Chen H., Wu Y. Clinical implications of Girdin and PI3K protein expression in breast cancer. Oncol Lett 2013, 5:1549-1553.
53. Skvortsova I., Skvortsov S., Raju U., Stasyk T., Riesterer O., Schottdorf E.M., et al. Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiother Oncol 2010, 96:108-115.
54. Biddle A., Mackenzie I.C. Cancer stem cells and EMT in carcinoma. Cancer Metastasis Rev 2012, PMID: 22302111.
55. Yoshida G.J., Saya H. Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. Biochem Biophys Res Commun 2014, 443:622-627.
56. Musha A., Yoshida Y., Takahashi T., Ando K., Funayama T., Kobayashi Y., et al. Synergistic effect of heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin and X-rays, but not carbon-ion beams, on lethality in human oral squamous cell carcinoma cells. J Radiat Res 2012, 53:545-550.
57. Quesnel B. Tumor dormancy: long-term survival in a hostile environment. Adv Exp Med Biol 2013, 734:181-200.
58. Vinogradov S., Wei X. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond) 2012, 7:597-615.
59. Pawlowski K.M., Mucha J., Majchrzak K., Motyl T., Krol M. Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells. BMC Vet Res 2013, 9:119.
60. Gatti L., Cossa G., Beretta G.L., Zaffaroni N., Perego P. Novel insights into targeting ATP-binding cassette transporters for antitumor therapy. Curr Med Chem 2011, 18:4237-4249.
61. Ingram W.J., Crowther L.M., Little E.B., Freeman R., Harliwong I., Veleva D., et al. ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp Hematol Oncol 2013, 2:26.
62. Lin T., Islam O., Heese K. ABC transporters, neural stem cells and neurogenesis - a different perspective. Cell Res 2006, 16:857-871.
63. Golebiewska A., Brons N.H., Bjerkvig R., Niclou S.P. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell 2011, 8:136-147.